Loading...

Pacific Edge Limited

PEB.AXASX
Healthcare
Medical - Diagnostics & Research
A$0.09
A$0.00(0.00%)

Pacific Edge Limited (PEB.AX) Stock Competitors & Peer Comparison

See (PEB.AX) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PEB.AXA$0.09+0.00%69M-2.83-A$0.03N/A
SHL.AXA$27.34-1.30%13.6B24.22A$1.14+3.88%
IDX.AXA$2.68+0.37%993.8M133.50A$0.02+2.17%
HLS.AXA$0.76-1.95%559.1M-0.80-A$0.96+82.44%
ACL.AXA$2.71-3.21%538M18.40A$0.15+4.53%
MVF.AXA$0.80+0.63%311.7M-80.00-A$0.01+6.38%
GSS.AXA$0.34+2.41%75M-3.30-A$0.10N/A
LDX.AXA$0.08+10.96%54.6M-7.30-A$0.01N/A
MAP.AXA$0.09-3.26%47.4M-3.07-A$0.03N/A
IIQ.AXA$0.40+8.22%43M-5.50-A$0.07N/A
Showing 1 to 10 of 16 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

PEB.AX vs SHL.AX Comparison August 2025

PEB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PEB.AX stands at 69M. In comparison, SHL.AX has a market cap of 13.6B. Regarding current trading prices, PEB.AX is priced at A$0.09, while SHL.AX trades at A$27.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PEB.AX currently has a P/E ratio of -2.83, whereas SHL.AX's P/E ratio is 24.22. In terms of profitability, PEB.AX's ROE is -0.86%, compared to SHL.AX's ROE of +0.07%. Regarding short-term risk, PEB.AX is more volatile compared to SHL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for PEB.AX.Check SHL.AX's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;